Study of the efficacy of the acute phase therapy for Kawasaki disease based on a new Shizuoka protocol 2016
Not Applicable
- Conditions
- Kawasaki disease
- Registration Number
- JPRN-UMIN000025707
- Lead Sponsor
- Shizuoka Kawasaki Disease Study Group
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 500
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who are diagnosed as Kawasaki disease but refuse to participate in this study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The effectiveness is estimated by the incidence of CAL one month after onset.
- Secondary Outcome Measures
Name Time Method